A PLOS Digital Health opinion argues that AI could ease routine evidence work, but fairer digital-health evidence will also require broader research capacity and careful oversight.
A published protocol outlines a review to map evidence on remimazolam sedation for older adults having gastrointestinal endoscopy, while stressing that it cannot yet establish comparative safety or effectiveness.
A review of 42 studies finds recurring links between lower vitamin D and uterine fibroids, but says uneven, mostly observational evidence cannot show whether the relationship is causal.
An online survey found uneven digitization across responding German neonatal units: core bedside records often remained paper-based, while physicians broadly favored upgrades and cited IT staffing and equipment costs as barriers.
A U.S. analysis of 50,630 adult liver-transplant hospitalizations found infections in 29.9% of cases, with adjusted links to higher mortality, more complications, longer stays and greater costs.
A survey of 500 active users in Israel found generally favorable views of primary-care messaging, while response-time and care-follow-up ratings lagged and service-design ideas remain untested.
A study of 5,787 Mpox-related tweets compared epidemic-style models of misinformation spread; an added exposure stage represents delayed sharing, but the burst-heavy dataset cannot validate broad forecasts.
An exploratory study in Kinshasa found measurable facial differences associated with sickle cell disease, but its internally tested model needs longitudinal and external validation before its clinical meaning is clear.
An argument in PLOS Medicine says paediatric HIV and TB care in Africa should support caregivers’ mental health too, while noting that evidence linking such support to children’s outcomes remains incomplete.
A study of 72 adults with ATLL links higher UHRF1 protein to worse survival and finds that silencing it slows two cell lines, but the biomarker and mechanism still need broader validation.
A qualitative Hajj study found gaps in pilgrims’ and nurses’ understanding of UV protection, with spiritual beliefs and practical barriers shaping use and researchers urging clearer, culturally appropriate education.
A RECOVER-NEURO report describes how one hub coordinated remote interventions across 22 U.S. sites, while the authors caution that feasibility in one trial does not establish scalability or clinical benefit.